Company intelligence / Profile preview

MindMics

Cambridge, Massachusetts, United Statesmindmics.com ↗

Ownership: Private
Development stage: Commercial

Overview

MindMics’ infrasonic hemodynography technology has been clinically validated to measure heart rate and heart rate variability with 99% accuracy compared to ECG, including in complex arrhythmias like atrial fibrillation. Studies with Prisma Health and Scripps Clinic have shown equivalence or superiority to gold-standard cardiac diagnostics for certain metrics. The system is being further studied for detection of valvular disease and aortic stenosis.

Therapeutic areas: PsychiatryCardiovascular
Modalities: DeviceNon-pharmacological therapy (wearable biometric monitoring)
Industry: Physiological Monitoring

Partnerships

Prisma Health (clinical validation partner)Scripps Clinic/Scripps Health (clinical research partner)

Beyond the preview

Go deeper on MindMics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MindMics.

Explore the full profile